tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Esther Rajavelu, 68 are a BUY (80.95%), 6 are a SELL (7.14%), 10 are a HOLD (11.9%).
Analyst Esther Rajavelu, carries an average stock price target met ratio of 57.36% that have a potential upside of 23.92% achieved within 278 days. Previously, Esther Rajavelu worked at UBS, DEUTSCHE BANK, JPMORGAN, OPPENHEIMER.
Esther Rajavelu’s has documented 175 price targets and ratings displayed on 23 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 15-Oct-2026.
Analyst best performing recommendations are on VNDA (VANDA PHARMACEUTICALS).
The best stock recommendation documented was for VNDA (VANDA PHARMACEUTICALS) at 2/14/2019. The price target of $21 was fulfilled within 1 day with a profit of $0.88 (4.37%) receiving and performance score of 43.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jul-2025
$225
$69.06 (44.29%)
$315
7 days ago
(02-Nov-2026)
4/10 (40%)
$60 (36.36%)
11
Buy Since 17-Dec-2018
$323
$167.06 (107.13%)
$429
7 days ago
(02-Nov-2026)
14/17 (82.35%)
$158 (95.76%)
319
Buy Since 28-Jun-2024
$380
$224.06 (143.68%)
$450
7 days ago
(02-Nov-2026)
1/6 (16.67%)
$215 (130.30%)
110
Buy Since 30-Oct-2026
$315
$159.06 (102.00%)
$333
10 days ago
(30-Oct-2026)
6/7 (85.71%)
$150 (90.91%)
153
Buy Since 20-Sep-2022
$280
$124.06 (79.56%)
$345
10 days ago
(30-Oct-2026)
31/39 (79.49%)
$115 (69.70%)
180
Which stock is Esther Rajavelu most bullish on?
Which stock is Esther Rajavelu most reserved on?
